Clinical Trials in Beijin, China
2 recruiting
Showing 1–9 of 9 trials
Recruiting
Not Applicable
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation1,616 enrolled50 locationsNCT06959524
Recruiting
Phase 3
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Small Cell Lung Cancer
Akeso560 enrolled53 locationsNCT07010263
Recruiting
Not Applicable
The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia
PainFibromyalgiaPregabalin+1 more
Beijing Tiantan Hospital750 enrolled2 locationsNCT07186751
Recruiting
Phase 2
Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
Myelodysplastic Syndromes
Institute of Hematology & Blood Diseases Hospital, China236 enrolled5 locationsNCT06918834
Recruiting
Phase 4
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
SurgeryBladder CancerCancer Recurrence+2 more
Peking University First Hospital1,128 enrolled6 locationsNCT04532606
Recruiting
Phase 1
Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing
Preeclampsia
Xiamen Amoytop Biotech Co., Ltd.30 enrolled1 locationNCT06924385
Recruiting
Not Applicable
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
Acute Coronary Syndrome (ACS)
Harbin Medical University1,860 enrolled18 locationsNCT06365502
Recruiting
Phase 1
Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
Ewing Sarcoma
Peking University People's Hospital44 enrolled3 locationsNCT06340204
Recruiting
Phase 2
Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy
Head and Neck Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences84 enrolled1 locationNCT05777824